Showing results (381-390 of 889) with videos related to
Sort By:
Pageof 89
Drugs in R&D|August 23, 2024
Targeting Non-V600 Mutations in BRAF: A Single Institution Retrospective Analysis and Review of the LiteratureHirra A Chaudhary, Timothy L Cannon, Arthur WinerDrugs in R&D|June 13, 2024
Effects of Body Mass Index on Hypertriglyceridemia Associated with Oral Bexarotene Therapy: A Post Hoc Analysis of an Open-Label Comparative Clinical Study of Combined Bexarotene and Phototherapy Versus Bexarotene Monotherapy for Japanese Patients with Cutaneous T-Cell LymphomaAkimasa Sanagawa, Tomoaki Hayakawa, Aya Yamamoto, et al.Drugs in R&D|May 22, 2024
Pharmacokinetics of a Fixed-Dose Combination Product of Amlodipine, Losartan, Ezetimibe, and Rosuvastatin and Its Comparison with Co-administration of Four Individual Components in Healthy ParticipantsJin-Woo Park, Hyewon Chung, Jong-Min Kim, et al.Drugs in R&D|August 26, 2023
Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to AdalimumabYijia Jiang, Taruna Arora, Scott Klakamp, et al.Drugs in R&D|October 7, 2020
Comparisons of Four Protein-Binding Models Characterizing the Pharmacokinetics of Unbound Phenytoin in Adult Patients Using Non-Linear Mixed-Effects ModelingHeajin Jun, Yan Rong, Catharina Yih, et al.Drugs in R&D|February 23, 2018
15 Years of Experience with Biphasic Insulin Aspart 30 in Type 2 DiabetesAndreas Liebl, Viswanathan Mohan, Wenying Yang, et al.Drugs in R&D|March 20, 2020
Dolutegravir-Based Antiretroviral Regimens for HIV Liver Transplant Patients in Real-Life SettingsDario Cattaneo, Salvatore Sollima, Paola Meraviglia, et al.Drugs in R&D|June 9, 2021
Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies?Reinhart Speeckaert, Jo Lambert, Luis Puig, et al.Drugs in R&D|September 30, 2015
Stability of Crushed Tedizolid Phosphate Tablets for Nasogastric Tube AdministrationGerard Kennedy, Jim Osborn, Shawn Flanagan, et al.Drugs in R&D|March 31, 2016
Dual Bronchodilator Therapy with Umeclidinium/Vilanterol Versus Tiotropium plus Indacaterol in Chronic Obstructive Pulmonary Disease: A Randomized Controlled TrialChris Kalberg, Dianne O'Dell, Dmitry Galkin, et al.Pageof 89